Livewire Ergogenics, Inc. LVVV Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Livewire Ergogenics, Inc. LVVV Company Overview 

Stock Message Board http://investorshangout.com/search?q=LVVV&...mp;yt1=Go!

Livewire Ergogenics, Inc. LVVV Current Price and Quotes
Last Price 0.015
Previous Close 0.014 Open 0.014
Daily Range 0.016 - 0.014 52wk Range 0.2667 - 0.004
Volume 438,600 Dividend N/A
Average Vol (3m) 462,097 Yield N/A
Livewire Ergogenics, Inc. LVVV

Company Verified Profile
Company Information

1747 S. Douglass Rd.
Unit C
Anaheim, CA 92806

Website: http://www.livewireenergy.com
Phone: 714-940-0155
Email: ir@livewireenergy.com
Find us on:    

Livewire Ergogenics, Inc. LVVV
Livewire Ergogenics Inc. develops, markets, sells, and distributes consumable energy supplements. It offers soft chews under the LiveWire Energy brand through retail and online stores. The company was founded in 2008 and is based in Anaheim, California.

Livewire Ergogenics, Inc. LVVV
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001421289
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2060 - Sugar & Confectionery Products
Business Status Development Stage Company a/o Dec 08, 2011
Incorporated In: NV, USA
Year of Inc. 2008
Employees 6 a/o Dec 08, 2011
Company Officers/Contacts

Bill Hodson CEO, Treasurer
Brad J. Nichols President, COO
Company Directors

Not Available
Company Notes

Formerly=SF Blu Vu, Inc. until 10-2011
Formerly=Semper Flowers, Inc. until 8-2009
Service Providers

Auditor/Accountant
RBSM LLP
805 Third Avenue
Suite 902
New York, NY, 10022
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
IRvox Communications

Livewire Ergogenics, Inc. LVVV
LVVV Security Details

Share Structure

Market Value1 $1,139,085 a/o Sep 13, 2013
Shares Outstanding 75,939,033 a/o Aug 08, 2013
Float 33,039,588 a/o Aug 02, 2013
Authorized Shares 100,000,000 a/o May 01, 2013
Par Value  No Par Value
Shareholders

Shareholders of Record 88 a/o Apr 16, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Jan 16, 2013 Jan 18, 2013 Feb 06, 2013
Dividend (0.00) Jan 16, 2013 Jan 18, 2013 Feb 06, 2013
Security Notes

Capital Change=shs increased by 1.2 for 1 split. Ex-date=01/16/2013. Rec date=01/18/2013. Pay date=02/06/2013.
Short Selling Data

Short Interest 1,460 (-87.7%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Livewire Ergogenics, Inc. LVVV Recent News

Sept 9, 2013 LiveWire Ergogenics, Inc. Files Form 8-K Announcing Entry Into a Material Definitive Agreement
Aug 30, 2013 LiveWire Ergogenics, Inc. Announces Cancellation of Letter of Intent Relating to an Asset Purchase and Royalty Agreement With Adia Nutrition, Inc.
Aug 29, 2013 LiveWire Ergogenics, Inc. Announces Continued Growth Throughout North East
Jul 11, 2013 LiveWire Ergogenics, Inc. Opens European Distribution Channel With Initial Order From Slovakia


Livewire Ergogenics, Inc. LVVV Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 148 402 148 -
Cost of Revenue 137 258 91 -
Gross Profit 11 144 56 -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,676 531 250 43
Non-Recurring Items - - - -
Other 6 4 - -
Operating Income (1,671) (391) (194) (43)
Income From Continuing Operations

Add'l Income/Expense Items (11) - - 10
Earnings Before Interest and Tax (1,682) (391) (194) (33)
Interest Expense 21 2 11 -
Earnings Before Tax (1,703) (393) (205) (33)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,703) (393) (205) (33)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,703) (393) (205) (33)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,703) (393) (205) (33)

LVVV Livewire Ergogenics, Inc. Research DD Guide

LVVV Livewire Ergogenics, Inc. Stock Message Board http://investorshangout.com/search?q=LVVV&...mp;yt0=Go!
LVVV Livewire Ergogenics, Inc. Stock Quote http://www.otcmarkets.com/stock/LVVV/quote
LVVV Livewire Ergogenics, Inc. Stock Chart http://www.otcmarkets.com/stock/LVVV/chart
LVVV Livewire Ergogenics, Inc. Company Info http://www.otcmarkets.com/stock/LVVV/company-info
LVVV Livewire Ergogenics, Inc. Recent News http://www.otcmarkets.com/stock/LVVV/news
LVVV Livewire Ergogenics, Inc. Financials http://www.otcmarkets.com/stock/LVVV/financials
LVVV Livewire Ergogenics, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/LVVV/filings
LVVV Livewire Ergogenics, Inc. Short Sales http://www.otcmarkets.com/stock/LVVV/short-sales
LVVV Livewire Ergogenics, Inc. Insider Disclosure http://www.otcmarkets.com/stock/LVVV/insider-transactions
LVVV Livewire Ergogenics, Inc. Research Reports http://www.otcmarkets.com/stock/LVVV/research
LVVV Livewire Ergogenics, Inc. Summary http://finance.yahoo.com/q?s=LVVV
LVVV Livewire Ergogenics, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=LVVV+Historical+Prices
LVVV Livewire Ergogenics, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=LVVV
LVVV Livewire Ergogenics, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=LVVV+Basic+Chart
LVVV Livewire Ergogenics, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LVVV+Basic+Tech.+Analysis
LVVV Livewire Ergogenics, Inc. Headlines http://finance.yahoo.com/q/h?s=LVVV+Headlines
LVVV Livewire Ergogenics, Inc. Press Releases http://finance.yahoo.com/q/p?s=LVVV+Press+Releases
LVVV Livewire Ergogenics, Inc. Company Profile http://finance.yahoo.com/q/pr?s=LVVV+Profile
LVVV Livewire Ergogenics, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=LVVV+Key+Statistics
LVVV Livewire Ergogenics, Inc. Industry http://finance.yahoo.com/q/in?s=LVVV+Industry
LVVV Livewire Ergogenics, Inc. Major Holders http://finance.yahoo.com/q/mh?s=LVVV+Major+Holders
LVVV Livewire Ergogenics, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=LVVV+Insider+Transactions
LVVV Livewire Ergogenics, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=LVVV+Insider+Roster
LVVV Livewire Ergogenics, Inc. Income Statement http://finance.yahoo.com/q/is?s=LVVV
LVVV Livewire Ergogenics, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=LVVV
LVVV Livewire Ergogenics, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=LVVV+Cash+Flow&annual
LVVV Livewire Ergogenics, Inc. Nasdaq http://www.nasdaq.com/symbol/LVVV
LVVV Livewire Ergogenics, Inc. Market Watch http://www.marketwatch.com/investing/stock/LVVV
LVVV Livewire Ergogenics, Inc. Bloomberg http://www.bloomberg.com/quote/LVVV:US
LVVV Livewire Ergogenics, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=LVVV
LVVV Livewire Ergogenics, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=LVVV
LVVV Livewire Ergogenics, Inc. Barchart http://www.barchart.com/quotes/stocks/LVVV
LVVV Livewire Ergogenics, Inc. OTC Short Report http://otcshortreport.com/index.php?index=LVVV
LVVV Livewire Ergogenics, Inc. Investopedia http://www.investopedia.com/markets/stocks/LVVV/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 140

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Response to Aluminium Tariff Threats and Implications

Updated Category News Views 121

Market Insights on Aluminium Pricing and Tariffs The aluminium market has been under scrutiny as recent events unfold regarding potential tariffs on Canadian imports. Despite rising aluminium prices for U.S. consumers since the presidential election, the increase has remained relatively moderate. This suggests that industry players are not overly concerned about the...

Continue Reading
Understanding the Booming Healthcare Asset Management Market

Updated Category News Views 230

Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...

Continue Reading
T1 Energy Inc. Faces Shareholder Investigation: What You Need to Know

Updated Category News Views 454

Understanding the Investigation of T1 Energy Inc. T1 Energy Inc. (NYSE: TE) is currently the focus of an important investigation launched by Purcell & Lefkowitz LLP, aimed at safeguarding the rights of its shareholders. This inquiry is centered on whether the directors have acted in accordance with their fiduciary duties regarding significant recent corporate actions. Why...

Continue Reading
Kimberly-Clark's Strategic Move to Shape Health and Wellness Market

Updated Category News Views 183

Kimberly-Clark's Transformative Acquisition In a remarkable move to bolster its position in the personal care products sector, Kimberly-Clark Corporation is poised to acquire Kenvue. This acquisition will create a formidable entity within the health and wellness market, valued at an impressive $32 billion. Kimberly-Clark, recognized for its commitment to sustainability...

Continue Reading
ADC Therapeutics Welcomes New Talent with Employee Grants

Updated Category News Views 106

ADC Therapeutics Expands Team with New Inducement Grant ADC Therapeutics SA (NYSE: ADCT), a leader in the field of antibody drug conjugates (ADCs), recently made headlines by offering a grant of options to acquire 6,000 of the company's common shares to a newly hired employee. This strategic move highlights the company's commitment to attracting top talent essential for...

Continue Reading